Literature DB >> 23812454

Overtreatment in a see-and-treat approach to cervical intraepithelial lesions.

Remko P Bosgraaf1, Peter-Paul Mast, Petronella H T H Struik-van der Zanden, Johan Bulten, Leon F A G Massuger, Ruud L M Bekkers.   

Abstract

OBJECTIVE: To determine the overtreatment rate at colposcopy in women who underwent a see-and-treat protocol.
METHODS: We identified 3,192 patients (mean age 36 years, standard deviation 8.7) who underwent a see-and-treat protocol in Radboud University Nijmegen Medical Center between January 1981 and December 2010. Overtreatment, defined as cervical intraepithelial neoplasia 1 or less at final histopathology analysis, was investigated in relation to the age of the women, time of referral, cervical smear result, colposcopic impression, and histopathology result.
RESULTS: A total of 579 women (18.1%, 95% confidence interval [CI] 16.7-19.5) were overtreated. The lowest overtreatment rate (4.5%, 95% CI 3.5-5.5) was seen in women with both a high-grade cervical smear result and a high-grade colposcopic impression. Women aged younger than 40 years were less likely to be overtreated (13.1%, 95% CI 11.7-14.5) than women aged 40-49 years (24.2% 95% CI 21.2-27.4, number needed to harm nine) and aged 50 years and older (42.2%, 95% CI 36.5-47.7, number needed to harm three).
CONCLUSIONS: The overtreatment rate is low for patients with both a high-grade smear result and a high-grade colposcopic impression, justifying a see-and-treat approach for these patients. In women with either a high-grade smear result or a high-grade impression on colposcopy, a see-and-treat approach may still be preferable but has higher overtreatment rates. Given the side effects of cervical surgery on pregnancy outcome, young women, in particular those who have either a low-grade smear result or low-grade impression on colposcopy, are better served by a two-step approach. In older women, a see-and-treat policy may be preferable.

Entities:  

Mesh:

Year:  2013        PMID: 23812454     DOI: 10.1097/AOG.0b013e318293ab22

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis.

Authors:  Michelle I Silver; Jeff Andrews; Charles K Cooper; Julia C Gage; Michael A Gold; Michelle J Khan; L Stewart Massad; Valentin Parvu; Rebecca B Perkins; Mark Schiffman; Katie M Smith; Nicolas Wentzensen
Journal:  Obstet Gynecol       Date:  2018-09       Impact factor: 7.661

2.  See-and-Treat for High-Grade Cytology: Do Young Women Have Different Rates of High-Grade Histology?

Authors:  Haller J Smith; Charles A Leath; Warner K Huh; Britt K Erickson
Journal:  J Low Genit Tract Dis       Date:  2016-07       Impact factor: 1.925

3.  Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical Precancer.

Authors:  Van T Nghiem; Kalatu R Davies; J Robert Beck; Michele Follen; Scott B Cantor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-29       Impact factor: 4.254

4.  5-aminolevulinic-acid-based fluorescence spectroscopy and conventional colposcopy for in vivo detection of cervical pre-malignancy.

Authors:  Rasa Vansevičiūtė; Jonas Venius; Olga Žukovskaja; Daiva Kanopienė; Simona Letautienė; Ričardas Rotomskis
Journal:  BMC Womens Health       Date:  2015-04-17       Impact factor: 2.809

5.  Antitumor activity of G-quadruplex-interactive agent TMPyP4 with photodynamic therapy in ovarian carcinoma cells.

Authors:  Hongli Liu; Changshuai Lv; Baijuan Ding; Jie Wang; Shan Li; Youzhong Zhang
Journal:  Oncol Lett       Date:  2014-05-08       Impact factor: 2.967

6.  Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population.

Authors:  Stephanie S Liu; Karen K L Chan; Tina N Wei; Ka Yu Tse; Siew F Ngu; Mandy M Y Chu; Lesley S K Lau; Annie N Y Cheung; Hextan Y S Ngan
Journal:  PLoS One       Date:  2022-08-05       Impact factor: 3.752

7.  DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women.

Authors:  A Boers; R P Bosgraaf; R W van Leeuwen; E Schuuring; D A M Heideman; L F A G Massuger; V M J Verhoef; J Bulten; W J G Melchers; A G J van der Zee; R L M Bekkers; G B A Wisman
Journal:  Br J Cancer       Date:  2014-07-17       Impact factor: 7.640

8.  Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy.

Authors:  Clare A Aitken; Albert G Siebers; Suzette M Matthijsse; Erik E L Jansen; Ruud L M Bekkers; Jeroen H Becker; Bram Ter Harmsel; Jan-Paul W R Roovers; Folkert J van Kemenade; Inge M C M de Kok
Journal:  Acta Obstet Gynecol Scand       Date:  2019-02-27       Impact factor: 3.636

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.